>> Black Swan Analysis Blog

Black Swan Analysis Blog

Pharmaceutical Pricing Challenges; USA perspective

On July 04, 2019, Tags Pricing Strategies

The pharmaceutical pricing landscape is by the most convoluted system and the main culprit of this is the USA. The pricing structure of the pharmaceuticals is by no means transparent and requires...

Impact of International Reference Pricing on Five Products in the USA

On June 13, 2019, Tags Pricing Strategies

Black Swan Analysis had a poster accepted at ISPOR USA 2019 in New Orleans titled “Impact of international reference pricing on five products in the USA”.

Rx Price IndexTM

On May 24, 2019, Tags Pricing Strategies

The Rx Price IndexTM is an online database that lists all licensed available pharmaceutical products in the European Union and other Markets.  By displaying pricing information from June 2015 to the...

Drug Pricing Transparency in the U.S: A Governmental Perspective

On April 18, 2019, Tags Pricing Strategies

The high cost of prescription drugs has been a major issue in the U.S, for decades. This is supportive of the fact the U.S spends twice as much on prescription drugs as other comparable western...

Black Swan Analysis - The Drug Pricing Saviour You've Been Looking For

On April 26, 2018, Tags Pricing Strategies

When it comes to making pharmaceutical forecasts and market access analysis, data quality can make or break the process. Launching a new product in multiple markets beyond your own requires a...

Pricing Strategies For Pharmaceutical Products - How To Keep Up With Modern Healthcare Structures

On February 20, 2018, Tags Pricing Strategies

Pharmaceutical prices are known to experience big fluctuations over short time frames. A dynamic pricing strategy should take into account the different factors that influence buying decisions, in...

1
New Call-to-action

Subscribe to Email Updates

New call-to-action
RX Brochure CTA Large

Recent Posts

Free Brochure Epiomic